Heinze, Sarah <br/><br/>
Depressive mood changes and psychiatric symptoms during 12-month low-dose interferon-alpha treatment in patients with malignant melanoma: results from the multicenter DeCOG trial.  [electronic resource] 

 -  Journal of immunotherapy (Hagerstown, Md. : 1997)  Jan 2010 
 - 106-14 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1537-4513 
<br/><br/><label>Standard No.: </label>10.1097/CJI.0b013e3181b8bdb9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents--adverse effects<br/>Depressive Disorder--chemically induced<br/>Female<br/>Humans<br/>Interferon-alpha--adverse effects<br/>Male<br/>Melanoma--drug therapy<br/>Middle Aged<br/>Mood Disorders--chemically induced<br/>Personality Disorders--chemically induced<br/>Psychiatric Status Rating Scales<br/>Risk Factors<br/>Skin Neoplasms--drug therapy